New Insulin Lawsuit, Idaho Antitrust Claim Tossed And More

Major insulin makers Eli Lilly, Novo Nordisk and Sanofi and the three largest pharmacy benefit managers have been hit with a fresh lawsuit accusing them of artificially inflating the cost of...

Already a subscriber? Click here to view full article